Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

Also called NCT07275697

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07275697
  • EU CT 2025-524182-25-00
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Sweden (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07275697. Randomized; single masking; primary purpose treatment. Start 2026-03-23 (actual); primary completion 2028-12-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study
Acronym
WAIT
Condition
Atrial Fibrillation (AF)
Condition
Obesity & Overweight
Intervention (Drug)
Semaglutide 2.4 mg
Intervention (Behavioral)
Standard medical treatment
Lead sponsor
Emma Svennberg (class: other)
Collaborator
Karolinska Institutet (class: other)

Record details

Record id
cardio:ct-nct07275697
Content hash
827053bb32afb80e743a24f19bc1469d31b31dc58a943afdc1cc28a372ef7451